IME 2022 and Beyond

We launched the IME (Independent Medical Examination) Campaign fall of 2022, to reach B2B Decision Makers and Adjusters of Insurance companies with A/B testing to target each audience. The goal is to make the adjuster's life easy so they will choose Enlyte for an IME referral with the catchy headline: Get your TIME back, and build strategies for better claim clarity for Decision Makers with the headline: Reimagine your IME process. Quality IMEs put a claim info focus and help determine the true cause of an injured employee’s complaints. The campaign includes the following: HTML5 display ads with motion graphics (sizes: 300x250, 336x280, 300x600, 728x90, 320x50), static ads (sizes: 330x100, 600x100) and several social media LinkedIn ads, a pillar page (https://www.genexservices.com/why-genex-ime), web design/development, White Paper page layout downloadable from the pillar page and emails marketing campaign. This campaign will carry on into 2023 and expand into new social posts, more ads, more A/B testing for landing pages per audience and more. We're making IME stand out in the crowd with the newly designed Enlyte brand.